| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | A Azzi | |
| Adelina Munteanu | |||
| J-M Zingg | |||
| P2860 | cites work | Identification of a low molecular mass (14.2 kDa) alpha-tocopherol-binding protein in the cytosol of rat liver and heart | Q72632744 |
| Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis | Q73081865 | ||
| Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation | Q73091616 | ||
| Alternatively spliced mRNA molecules of the thrombospondin receptor (CD36) in human PBMC | Q73161680 | ||
| Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial | Q73176018 | ||
| Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes | Q73176765 | ||
| Vitamin E supplementation and cardiovascular events in high-risk patients | Q73365511 | ||
| Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene | Q73428672 | ||
| Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs | Q73450832 | ||
| Relative Effects of alpha- and gamma-Tocopherol on Low-Density Lipoprotein Oxidation and Superoxide Dismutase and Nitric Oxide Synthase Activity and Protein Expression in Rats | Q73469026 | ||
| Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein | Q73584168 | ||
| alpha-Tocopherol transfer protein gene: exon skipping of all transcripts causes ataxia | Q73624587 | ||
| dl-alpha-tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells | Q73668865 | ||
| Alpha-tocopherol protects against monocyte Mac-1 (CD11b/CD18) expression and Mac-1-dependent adhesion to endothelial cells induced by oxidized low-density lipoprotein | Q73676062 | ||
| Alpha-tocopherol downregulates the expression of GPIIb promoter in HEL cells | Q73699469 | ||
| Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells | Q73954435 | ||
| The metabolism of vitamin E. I. The absorption and excretion of d-alpha-tocopheryl-5-methyl-C14-succinate | Q74214838 | ||
| The metabolism of vitamin E. II. Purification and characterization of urinary metabolites of alpha-tocopherol | Q74214841 | ||
| Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia | Q74321489 | ||
| alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells | Q74382192 | ||
| Effect of alpha-tocopherol status on alpha-tocopherol transfer protein expression and its messenger RNA level in rat liver | Q74469664 | ||
| RRR-alpha-tocopherol regulation of gene transcription in response to the cell oxidant status | Q74478533 | ||
| The effect of alpha-tocopherol on the nitration of gamma-tocopherol by peroxynitrite | Q74587723 | ||
| Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase | Q77297728 | ||
| alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation | Q77604560 | ||
| Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells | Q77909392 | ||
| Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells | Q77918854 | ||
| Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations | Q93899193 | ||
| Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice | Q24623151 | ||
| Alpha-tocopherol modulates the low density lipoprotein receptor of human HepG2 cells | Q24800230 | ||
| Gamma (γ) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (γ) expression in SW 480 human colon cancer cell lines | Q24804408 | ||
| Alpha-tocopherol down-regulates scavenger receptor activity in macrophages | Q28137970 | ||
| Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico | Q28143207 | ||
| Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project | Q28176142 | ||
| Cloning of novel human SEC14p-like proteins: ligand binding and functional properties | Q28205288 | ||
| Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol | Q28298967 | ||
| Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E | Q28344980 | ||
| NF-kappaB: pivotal mediator or innocent bystander in atherogenesis? | Q28346544 | ||
| Effect of selenium and vitamin E deficiency on differential gene expression in rat liver | Q28579103 | ||
| Vitamin E analogues as inducers of apoptosis: structure-function relation | Q28751681 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Effects of vitamin E on lipid peroxidation in healthy persons | Q32084775 | ||
| Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement | Q33640407 | ||
| d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties | Q33654586 | ||
| The ambivalence of vitamin E in atherogenesis | Q33656491 | ||
| Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells | Q33905168 | ||
| Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages | Q33941623 | ||
| Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction | Q34067817 | ||
| gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention | Q34103259 | ||
| Vitamin E and macrophage cyclooxygenase regulation in the aged | Q34131834 | ||
| Effect of Vitamin E in Coronary Heart Disease | Q34148986 | ||
| Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells | Q34169724 | ||
| Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials | Q34206974 | ||
| Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells | Q34228843 | ||
| Vitamin E: protective role of a Janus molecule | Q34426272 | ||
| Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C. | Q34615767 | ||
| HDL is the major source of vitamin E for type II pneumocytes. | Q52976552 | ||
| Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply? | Q53999841 | ||
| Inter- and intra-individual variation in plasma and red blood cell vitamin E after supplementation. | Q54166560 | ||
| Rat liver alpha-tocopherol binding protein | Q54598201 | ||
| Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial | Q58075458 | ||
| Synthetic as compared with natural vitamin E is preferentially excreted as α-CEHC in human urine: studies using deuterated α-tocopheryl acetates | Q58320370 | ||
| Modulation by α- and γ-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells∗ | Q58863676 | ||
| Age-Associated Alterations in Splenic iNOS Regulation: Influence of Constitutively Expressed IFN-γ and Correction Following Supplementation with PPARα Activators or Vitamin E | Q59944211 | ||
| Peroxisome Proliferator-activated Receptor α Activation Modulates Cellular Redox Status, Represses Nuclear Factor-κB Signaling, and Reduces Inflammatory Cytokine Production in Aging | Q59944212 | ||
| Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study | Q60233031 | ||
| Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver | Q68019152 | ||
| Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis | Q68112461 | ||
| Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial | Q70984587 | ||
| Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) | Q71060539 | ||
| Novel urinary metabolite of d-delta-tocopherol in rats | Q71302251 | ||
| alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism | Q71785121 | ||
| Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes | Q72353109 | ||
| Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation | Q34743416 | ||
| Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death | Q34795697 | ||
| The European perspective on vitamin E: current knowledge and future research | Q34905197 | ||
| Regulation of cell signalling by vitamin E | Q35105487 | ||
| gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells | Q35307368 | ||
| Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice | Q35610718 | ||
| Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model | Q35774140 | ||
| Absorption, transport and metabolism of vitamin E. | Q37253869 | ||
| The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium | Q37358390 | ||
| A new endogenous natriuretic factor: LLU-alpha | Q37567918 | ||
| Vitamin E: antioxidant activity, biokinetics, and bioavailability | Q37946519 | ||
| Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. | Q38309468 | ||
| Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein | Q38347471 | ||
| Differential inhibition by alpha- and beta-tocopherol of human erythroleukemia cell adhesion: role of integrins | Q40801444 | ||
| Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells | Q40864542 | ||
| alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells | Q40993129 | ||
| alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state | Q41019160 | ||
| High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles | Q41045022 | ||
| Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators | Q41082185 | ||
| Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells | Q41413301 | ||
| Identification of a human CD36 isoform produced by exon skipping. Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1. | Q41486568 | ||
| Macrophages, oxidised lipids and atherosclerosis | Q41590187 | ||
| gamma-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage. | Q41630234 | ||
| Suppression of interleukin-1 beta and LDL scavenger receptor expression in macrophages by a selective protein kinase C inhibitor | Q41662939 | ||
| Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells. | Q41746797 | ||
| Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells | Q41812291 | ||
| alpha- and delta-tocopherol induce expression of hepatic alpha-tocopherol-transfer-protein mRNA. | Q42260208 | ||
| Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E. | Q42543689 | ||
| The effect of alpha-tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol 12-myristate 13-acetate down-regulation | Q42660227 | ||
| Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease | Q43569430 | ||
| Immunological dysregulation of lung cells in response to vitamin E deficiency | Q43615254 | ||
| alpha-Tocopherol, but not gamma-tocopherol inhibits 7 beta-hydroxycholesterol-induced apoptosis in human U937 cells | Q43791148 | ||
| Influences of alpha-tocopherol on cholesterol metabolism and fatty streak development in apolipoprotein E-deficient mice fed an atherogenic diet | Q43805548 | ||
| Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase | Q43912961 | ||
| Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial | Q43953917 | ||
| Prolonged, low dose alpha-tocopherol therapy counteracts intercellular cell adhesion molecule-1 activation | Q43975784 | ||
| Vitamin E inhibits IL-4 gene expression in peripheral blood T cells | Q44122410 | ||
| Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines | Q44156940 | ||
| Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins | Q44170561 | ||
| Alpha-tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits. | Q44195500 | ||
| Vitamin E activates gene expression via the pregnane X receptor | Q44264352 | ||
| γ‐Tocopherol, but not α‐tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats | Q44425145 | ||
| Monocyte chemoattractant protein-1 involvement in the alpha-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice | Q44502393 | ||
| Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease | Q44545033 | ||
| Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alpha. | Q46439781 | ||
| Inhibition of NF-kappa B activation by vitamin E derivatives | Q46571552 | ||
| Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein | Q47739528 | ||
| Regulation of recombinant PKC alpha activity by protein phosphatase 1 and protein phosphatase 2A. | Q47800337 | ||
| Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders | Q48259283 | ||
| Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. | Q50668749 | ||
| P433 | issue | 1 | |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 59-76 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Journal of Cellular and Molecular Medicine | Q1524063 |
| P1476 | title | Anti-atherosclerotic effects of vitamin E--myth or reality? | |
| P478 | volume | 8 |
| Q39863106 | 7-ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E: a specific role for alpha-tocopherol with consequences on cell death |
| Q115502625 | Academic myths of tourism |
| Q34308133 | Adherence to a Mediterranean diet and plasma concentrations of lipid peroxidation in premenopausal women |
| Q37043722 | Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells |
| Q36218888 | Alpha-tocopherol: roles in prevention and therapy of human disease |
| Q40331136 | Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma |
| Q39038155 | Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis |
| Q36700173 | Antioxidant vitamins and their use in preventing cardiovascular disease |
| Q34795616 | Antioxidative and antiatherogenic effects of flaxseed, α-tocopherol and their combination in diabetic hamsters fed with a high-fat diet |
| Q37104358 | Association between nutrient intake and peripheral artery disease: results from the InCHIANTI study |
| Q38682030 | Athero-inflammatory nanotherapeutics: Ferulic acid-based poly(anhydride-ester) nanoparticles attenuate foam cell formation by regulating macrophage lipogenesis and reactive oxygen species generation |
| Q46199990 | Bioactivity of vitamin E. |
| Q36266016 | Cardioprotective response to chronic administration of vitamin E in isoproterenol induced myocardial necrosis: Hemodynamic, biochemical and ultrastructural studies |
| Q36897274 | Conjugated linoleic acid modulation of risk factors associated with atherosclerosis |
| Q36625126 | Dietary effects on oxidation of low-density lipoprotein and atherogenesis |
| Q40073183 | Effects of lycopene on the induction of foam cell formation by modified LDL. |
| Q28290922 | Effects of new combinative antioxidant FeAOX-6 and alpha-tocotrienol on macrophage atherogenesis-related functions |
| Q33572265 | Emerging role for antioxidant therapy in protection against diabetic cardiac complications: experimental and clinical evidence for utilization of classic and new antioxidants |
| Q28219326 | Endothelial cell dysfunction and the vascular complications associated with type 2 diabetes: assessing the health of the endothelium |
| Q46788544 | Gene expression profile of high-fat diet-fed C57BL/6J mice: in search of potential role of azelaic acid |
| Q35734135 | Isoforms of Vitamin E Differentially Regulate Inflammation |
| Q37109304 | Isoforms of Vitamin E Differentially Regulate PKC α and Inflammation: A Review |
| Q37358930 | Isoforms of vitamin E have opposing immunoregulatory functions during inflammation by regulating leukocyte recruitment |
| Q64994861 | Lentinula edodes (shiitake mushroom): An assessment of in vitro anti-atherosclerotic bio-functionality. |
| Q48253329 | Long-Chain Metabolites of Vitamin E: Metabolic Activation as a General Concept for Lipid-Soluble Vitamins? |
| Q35688098 | OTC Antioxidant Products for the Treatment of Cardiovascular and other Disorders: Popular Myth or Fact? |
| Q38172089 | Oxidative stress-related biomarkers in essential hypertension and ischemia-reperfusion myocardial damage |
| Q38852365 | Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis |
| Q37048947 | Role of oxidants and antioxidants in atherosclerosis: results of in vitro and in vivo investigations |
| Q37017403 | Studies on free radicals, antioxidants, and co-factors |
| Q42750575 | The cardioprotective effects of a combination of quercetin and α-tocopherol on isoproterenol-induced myocardial infarcted rats |
| Q46451592 | The peroxynitrite evoked contractile depression can be partially reversed by antioxidants in human cardiomyocytes |
| Q35151318 | Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants |
| Q36880063 | Vitamin E and mast cells |
| Q28571951 | Vitamin E deficiency induces liver nuclear factor-kappaB DNA-binding activity and changes in related genes |
| Q37076469 | Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection |
| Q36880085 | Vitamin E: inflammation and atherosclerosis |
Search more.